Literature DB >> 20008060

Barriers to follow-up of abnormal Papanicolaou smears among women in Leon, Nicaragua.

M B Vastbinder1, C Castillo, R L M Bekkers.   

Abstract

Cervical cancer screening programmes only succeed when the coverage, screening, treatment and follow-up of any abnormal results are of high quality. This study investigates the screening coverage and the quality of the follow-up of cervical cancer screening of women in León, Nicaragua, as well as the factors affecting coverage and barriers to follow-up. Two hundred and thirty-four sexually active women attending a public health centre (54), a public health post (63), or the gynaecology department of the public HEODRA hospital (117), were invited to answer an orally administered questionnaire. The screening coverage of cervical cancer was calculated and the follow-up after finding an abnormal screening result was assessed. The coverage was 60.6% (95% confidence interval 54.4-66.8%). One hundred and sixty-eight women (87%) were informed about the results. Eighteen (10, 7%) of the women who were informed about the results, were advised to have follow-up and 12 (66, 7%) of them did. Barriers to follow-up were financial constraints, pregnancy, postponement and absence of instruments/electricity. This study shows that the screening coverage and cytology services are adequate, but that there is insufficient follow-up and/or treatment after an abnormal screening result. In order to achieve a lower incidence and mortality of cervical cancer, follow-up and treatment after an abnormal screening result need to be improved. A visual inspection with acetic acid may be an attractive alternative.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008060     DOI: 10.1258/td.2009.090076

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

1.  Barriers to Follow-Up for Abnormal Papanicolaou Smears among Female Sex Workers in Lima, Peru.

Authors:  Devora Aharon; Martha Calderon; Vicky Solari; Patricia Alarcon; Joseph Zunt
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

2.  Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Authors:  Nicole G Campos; Mercy Mvundura; Jose Jeronimo; Francesca Holme; Elisabeth Vodicka; Jane J Kim
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.